Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
More precise dosing of acenocoumarol in patients aged 80 and above, a pilot study
2016-003086-25Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acenocoumarol in Atrial fibrillation (AFib) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Quality of anticoagulation. Started Jan 2017; status: active.
02
Drugs
acenocoumarol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2016-003086-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003086-25.